140 related articles for article (PubMed ID: 6682104)
1. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium (IV) compounds. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
J Cancer Res Clin Oncol; 1983; 105(1):109-10. PubMed ID: 6682104
[No Abstract] [Full Text] [Related]
2. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato) titanium(IV) compounds against Walker 256 carcinosarcoma. A new class of antineoplastic agents.
Keller HJ; Keppler B; Schmähl D
Arzneimittelforschung; 1982; 32(8):806-7. PubMed ID: 6890355
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
Mattern J; Keppler B; Volm M
Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of phenyl substituted dihalogenobis (1-phenyl-1,3-butanedionato)titanium (IV) compounds.
Keppler BK; Diez A; Seifried V
Arzneimittelforschung; 1985; 35(12):1832-6. PubMed ID: 4096739
[TBL] [Abstract][Full Text] [Related]
5. Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
Köpf-Maier P; Wagner W; Hesse B; Köpf H
Eur J Cancer (1965); 1981 Jun; 17(6):665-9. PubMed ID: 7308264
[No Abstract] [Full Text] [Related]
6. Antileukemic properties of organoplatinum complexes.
Meischen SJ; Gale GR; Lake LM; Frangakis CJ; Rosenblum MG; Walker EM; Atkins LM; Smith AB
J Natl Cancer Inst; 1976 Oct; 57(4):841-5. PubMed ID: 1003531
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
[TBL] [Abstract][Full Text] [Related]
8. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of dichlorobis(1-phenylbutane-1,3-dionato)titanium (IV) and budotitane. Two representatives of the new class of antitumor-active bis-beta-diketonato metal complexes.
Keppler BK; Schmähl D
Arzneimittelforschung; 1986 Dec; 36(12):1822-8. PubMed ID: 3566844
[TBL] [Abstract][Full Text] [Related]
10. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
Köpf-Maier P; Moormann A; Köpf H
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
[TBL] [Abstract][Full Text] [Related]
11. Autochthonous, acetoxymethylmethylnitrosamine-induced colorectal cancer in rats: a useful tool in selecting new active antineoplastic compounds?
Berger MR; Bischoff H; Garzon FT; Schmähl D
Hepatogastroenterology; 1986 Oct; 33(5):227-34. PubMed ID: 3804178
[TBL] [Abstract][Full Text] [Related]
12. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
Venditti JM; Wesley RA; Plowman J
Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
[No Abstract] [Full Text] [Related]
13. Evaluation of trans-tetrachloro-1,2-diaminocyclohexane platinum (IV) in murine leukemia L1210 resistant and sensitive to cis-diamminedichloroplatinum (II).
Wilkoff LJ; Dulmadge EA; Trader MW; Harrison SD; Griswold DP
Cancer Chemother Pharmacol; 1987; 20(2):96-100. PubMed ID: 3664938
[TBL] [Abstract][Full Text] [Related]
14. Lack of cross-resistance between certain platinum coordination compounds in mouse leukemia.
Burchenal JH; Kalaher K; O'Toole T; Chisholm J
Cancer Res; 1977 Sep; 37(9):3455-7. PubMed ID: 884687
[TBL] [Abstract][Full Text] [Related]
15. [Antineoplastic activity of complex compounds of platinum(IV)].
Presnov MA; Zheligovskaia NN; Babkov AV; Konovalova AL; Budanova NS
Dokl Akad Nauk SSSR; 1976 JUL-AUG; 229(1):226-9. PubMed ID: 954573
[No Abstract] [Full Text] [Related]
16. Antitumour action of planar, organometallic rhodium(I) complexes.
Giraldi T; Zassinovich G; Mestroni G
Chem Biol Interact; 1974 Dec; 9(6):389-94. PubMed ID: 4434566
[No Abstract] [Full Text] [Related]
17. Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane.
Vollano JF; Al-Baker S; Dabrowiak JC; Schurig JE
J Med Chem; 1987 Apr; 30(4):716-9. PubMed ID: 3560163
[TBL] [Abstract][Full Text] [Related]
18. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.
Köpf-Maier P
Cancer Chemother Pharmacol; 1989; 23(4):225-30. PubMed ID: 2924380
[TBL] [Abstract][Full Text] [Related]
19. [Antitumor properties of cis-dichlorodiamminedihydroxyplatinum (IV)].
Presnov MA; Konovalova AL; Kozlov AM; Brovtsyn VK; Romanova LF
Izv Akad Nauk SSSR Biol; 1986; (3):417-28. PubMed ID: 3734243
[No Abstract] [Full Text] [Related]
20. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
Köpf-Maier P; Hesse A
J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]